Editorials
Using gene set signature to guide hypothesis-driven experiments
Translational Cancer Research
2013;
2
(1)
:1-2
.
(05 March 2013)
From devils to jobs: tracking neuroendocrine tumors
Translational Cancer Research
2013;
2
(1)
:3-5
.
(05 March 2013)
Original Articles
Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma
Translational Cancer Research
2013;
2
(1)
:6-17
.
(05 March 2013)
A preliminary study of concurrent gains and losses across gene expression profiles and comparative genomic hybridization in Taiwanese breast cancer patients
Translational Cancer Research
2013;
2
(1)
:18-24
.
(05 March 2013)
Meta-Analysis
Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis
Translational Cancer Research
2013;
2
(1)
:25-32
.
(05 March 2013)
Review Article
Common applications of next-generation sequencing technologies in genomic research
Translational Cancer Research
2013;
2
(1)
:33-45
.
(05 March 2013)
Perspectives
Carboplatin, paclitaxel and sorafenib in advanced melanoma – what have we learned?
Translational Cancer Research
2013;
2
(1)
:46-47
.
(05 March 2013)
Is there still a role for tremelimumab in the treatment of cancer?
Translational Cancer Research
2013;
2
(1)
:48-50
.
(05 March 2013)
A new brainwave in non-small cell lung cancer: driving targeted therapy to central nervous system metastases
Translational Cancer Research
2013;
2
(1)
:51-53
.
(05 March 2013)
EGFR mutation status and brain metastases in non-small cell lung cancer: an understudied problem
Translational Cancer Research
2013;
2
(1)
:54-56
.
(05 March 2013)
Meeting Report
Focus on a recent molecular imaging workshop in India
Translational Cancer Research
2013;
2
(1)
:57-58
.
(05 March 2013)
